<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="letter"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="publisher-id">JOACP</journal-id><journal-id journal-id-type="publisher-id">J Anaesthesiol Clin Pharmacol</journal-id><journal-title-group><journal-title>Journal of Anaesthesiology, Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0970-9185</issn><issn pub-type="epub">2231-2730</issn><publisher><publisher-name>Wolters Kluwer - Medknow</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9438827</article-id><article-id pub-id-type="publisher-id">JOACP-38-143</article-id><article-id pub-id-type="doi">10.4103/joacp.joacp_412_21</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to Editor</subject></subj-group></article-categories><title-group><article-title>Apprising the need for a living guideline approach in the COVID-19 era</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Magoon</surname><given-names>Rohan</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>Ankur</given-names></name><xref rid="aff2" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Kapoor</surname><given-names>Poonam M.</given-names></name><xref rid="aff3" ref-type="aff">2</xref><xref rid="cor1" ref-type="corresp"/></contrib></contrib-group><aff id="aff1">Department of Cardiac Anaesthesia, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. Ram Manohar Lohia Hospital, Baba Kharak Singh Marg, New Delhi, India</aff><aff id="aff2"><label>1</label>Department of Haematology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India</aff><aff id="aff3"><label>2</label>Department of Cardiac Anaesthesia, Cardiothoracic Centre, CNC, All India Institute of Medical Sciences, New Delhi, Ansari Nagar, New Delhi, India</aff><author-notes><corresp id="cor1">
<bold>Address for correspondence:</bold> Dr. Poonam M. Kapoor, Department of Cardiac Anaesthesia, Cardiothoracic Centre, Room No. 8,7<sup>th</sup> Floor, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029, India. E-mail: <email xlink:href="docpoonamaiims@gmail.com">docpoonamaiims@gmail.com</email>
</corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>22</day><month>4</month><year>2022</year></pub-date><volume>38</volume><issue>Suppl 1</issue><fpage>S143</fpage><lpage>S144</lpage><history><date date-type="received"><day>15</day><month>8</month><year>2021</year></date><date date-type="rev-recd"><day>03</day><month>10</month><year>2021</year></date><date date-type="accepted"><day>18</day><month>10</month><year>2021</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2022 Journal of Anaesthesiology Clinical Pharmacology</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>Dear Editor,</p><p>The sheer pace of the global crisis emanating as a consequence of the coronavirus disease 2019 (COVID-19) pandemic has jolted the scientific community. Amidst a concerted research endeavor put forth by the scientific powerhouse, the COVID-19 related research has been accompanied by ardent debates regarding its reliability, robustness, and reproducibility.[<xref rid="R1" ref-type="bibr">1</xref>] While the real-time research challenges are understandably intensified in the view of a condensed time frame in an ongoing pandemic, the task of efficiently adapting to a rapidly evolving global situation has proven to be equally daunting for the clinical societies and regulatory bodies.[<xref rid="R1" ref-type="bibr">1</xref>]</p><p>Appropriate to the context, the pandemic times have motivated the interest of the guideline developers in the living guideline approach.[<xref rid="R2" ref-type="bibr">2</xref>] Defined as <italic toggle="yes">&#x0201c;an optimization of the</italic>
<italic toggle="yes">guideline development process to allow updating of individual recommendations as soon as</italic>
<italic toggle="yes">new relevant evidence becomes available,&#x0201d;</italic> the approach aims at the timely provision of trustworthy, evidence-based, decision-making advice for clinicians.[<xref rid="R3" ref-type="bibr">3</xref>] Alongside a development process adhering to high quality standards, the dynamic update of the individual recommendations is likely to add an incremental value.</p><p>Exemplified by the World Health Organisation&#x02019;s (WHO) recommendations on maternal and perinatal health, the living guideline approach captivates an enhanced attention for being peculiarly responsive to the emerging evidence.[<xref rid="R4" ref-type="bibr">4</xref>] A pandemic situation best heralds the need of a living guideline approach for a range of factors as enlisted in <xref rid="joacp_412_21-t001" ref-type="table">Table 1</xref>. Vandvik and colleagues[<xref rid="R5" ref-type="bibr">5</xref>] propose that employing the former can assist in fixing the cracks in the COVID-19 evidence pipeline.</p><table-wrap position="float" id="joacp_412_21-t001"><label>Table 1</label><caption><p>Factors propounding the need for living guidelines in COVID-19[<xref rid="R1" ref-type="bibr">1</xref><xref rid="R2" ref-type="bibr">2</xref><xref rid="R3" ref-type="bibr">3</xref><xref rid="R4" ref-type="bibr">4</xref><xref rid="R5" ref-type="bibr">5</xref>]</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">High prevalence of an unprecedented global disease <break/>Unanticipated complications, morbidity-mortality <break/>Heterogeneous practices, requirement of standardization <break/>Colossal research magnitude, including preprints <break/>Developing pragmatic preventive-diagnostic-therapeutic strategies <break/>Assisting bench-to-bedside translation, practical decision-making <break/>Dynamic outlook towards an evolving health problem <break/>Future preparedness</td></tr></tbody></table></table-wrap><p>This evidence-informed dynamic approach can function smoothly in the background of a meticulous literature monitoring, subsequent updating of systematic reviews for evidence synthesis, consultative prioritization procedure, and living guideline panels&#x02019; electronic consultations.[<xref rid="R3" ref-type="bibr">3</xref><xref rid="R4" ref-type="bibr">4</xref>] Herein, the recent research experience in COVID-19 is encouraging with respect to the dynamic update of a comprehensive set of recommendations based on living systematic reviews (LSR) and network meta-analysis published in scientific journals and those published as the Cochrane collaboration.[<xref rid="R2" ref-type="bibr">2</xref><xref rid="R5" ref-type="bibr">5</xref>] This is further assisted with the advent of artificial intelligence. The presence of structured data on interoperable user-friendly platforms such as MAGICapp allows for global dissemination of multilayered recommendations, interactive evidence synopsis, and decision-making aids. The pre-eminent guideline developing organizations like the WHO has come up with living guidelines on the prevention and treatment of COVID-19.[<xref rid="R2" ref-type="bibr">2</xref><xref rid="R5" ref-type="bibr">5</xref>]</p><p>Nevertheless, the transition towards a living guideline approach can only be successful and sustainable when backed by an augmented workflow of appropriate LSRs and an improved collaboration between the LSRs and living guideline teams. At the same time, the requirement of a significant capital, the need to minimize time-frame attributable to peer-reviews, defining thresholds for updating the recommendations and unified set of publication and dissemination procedure, necessitate simultaneous consideration.[<xref rid="R3" ref-type="bibr">3</xref>]</p><p>Amidst the present aim of optimizing programmes-practices and consolidating response to an evolving health crisis, the COVID-19 era reasonably apprises the need for the individual recommendations being continually updated, ahead of the thematic guidelines.[<xref rid="R5" ref-type="bibr">5</xref>] However, in a larger perspective, there is a potential need to foster a sound comprehension of the feasibility, productivity, validity, and impact of the living guideline approach on the evidence ecosystem, particularly prompted by the ever-intensifying research challenges.[<xref rid="R1" ref-type="bibr">1</xref><xref rid="R5" ref-type="bibr">5</xref>]</p><sec disp-level="2"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec sec-type="COI-statement" disp-level="2"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></body><back><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Magoon</surname><given-names>R</given-names></name>
<name><surname>Ohri</surname><given-names>R</given-names></name>
</person-group><article-title>Compounded research challenges amid the COVID-19 pandemic</article-title><source>Anaesth Crit Care Pain Med</source><year>2020</year><volume>39</volume><fpage>689</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">32947032</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Rochwerg</surname><given-names>B</given-names></name>
<name><surname>Agarwal</surname><given-names>A</given-names></name>
<name><surname>Siemieniuk</surname><given-names>RA</given-names></name>
<name><surname>Agoritsas</surname><given-names>T</given-names></name>
<name><surname>Lamontagne</surname><given-names>F</given-names></name>
<name><surname>Askie</surname><given-names>L</given-names></name>
<etal/>
</person-group><article-title>A living WHO guideline on drugs for covid-19</article-title><source>BMJ</source><year>2020</year><volume>370</volume><fpage>m3379</fpage><pub-id pub-id-type="pmid">32887691</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Akl</surname><given-names>EA</given-names></name>
<name><surname>Meerpohl</surname><given-names>JJ</given-names></name>
<name><surname>Elliott</surname><given-names>J</given-names></name>
<name><surname>Kahale</surname><given-names>LA</given-names></name>
<name><surname>Sch&#x000fc;nemann</surname><given-names>HJ</given-names></name>
</person-group><article-title>Living Systematic Review Network. Living systematic reviews: 4. Living guideline recommendations</article-title><source>J Clin Epidemiol</source><year>2017</year><volume>91</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">28911999</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Vogel</surname><given-names>JP</given-names></name>
<name><surname>Dowswell</surname><given-names>T</given-names></name>
<name><surname>Lewin</surname><given-names>S</given-names></name>
<name><surname>Bonet</surname><given-names>M</given-names></name>
<name><surname>Hampson</surname><given-names>L</given-names></name>
<name><surname>Kellie</surname><given-names>F</given-names></name>
<etal/>
</person-group><article-title>Developing and applying a &#x02018;living guidelines&#x02019; approach to WHO recommendations on maternal and perinatal health</article-title><source>BMJ Glob Health</source><year>2019</year><volume>4</volume><fpage>e001683</fpage></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Vandvik</surname><given-names>PO</given-names></name>
<name><surname>Askie</surname><given-names>L</given-names></name>
<name><surname>Glen</surname><given-names>F</given-names></name>
<name><surname>Tendal</surname><given-names>B</given-names></name>
<name><surname>Agoritsas</surname><given-names>T</given-names></name>
</person-group><article-title>COVID-19: Living guidelines help fix cracks in evidence pipeline</article-title><source>Nature</source><year>2021</year><volume>595</volume><fpage>172</fpage></element-citation></ref></ref-list></back></article>
